Icagen Agrees Licensing Deal with Pfizer
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 87 (Table of Contents)
Published: 7 Sep-2007
DOI: 10.3833/pdr.v2007.i87.291 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Icagen entered into a worldwide licensing agreement with Pfizer to discover, develop and commercialize sodium ion channel modulators for the treatment of pain, CNS disorders and inflammation...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS